Anne-Marie Halland
Cape Town Science Centre(ZA)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Lymphoma Diagnosis and Treatment, Autoimmune and Inflammatory Disorders Research, Lipoproteins and Cardiovascular Health, Orthopedic Surgery and Rehabilitation
Most-Cited Works
- → Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu(2010)413 cited
- → Tocilizumab Inhibits Structural Joint Damage and Improves Physical Function in Patients with Rheumatoid Arthritis and Inadequate Responses to Methotrexate: LITHE Study 2-year Results(2013)122 cited
- → Musculoskeletal manifestations in hyperlipidaemia: a controlled study.(1993)89 cited
- Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.(2016)
- A pilot study of the clinical effects of a mixture of beta-sitosterol and beta-sitosterol glucoside in active rheumatoid arthritis (RA).(2002)
- → SAT0103 Lithe: Tocilizumab (TCZ) Inhibits Radiographic Progression and Improves Physical Function in Patients (PTS) With Rheumatoid Arthritis (RA) at 5 Years With Maintenance of Clinical Efficacy Over Time(2013)7 cited
- → 95. Tocilizumab Inhibits Radiographic Progression And Improves Physical Function In Patients With Rheumatoid Arthritis At 5 Years With Maintenance Of Clinical Efficacy Over Time(2014)